Apollo makes a deal worth up to $926M; Abeona resubmits gene therapy

Plus, news about Centessa, Autolus Therapeutics, Zucara Therapeutics, Vindur Tx, Vittoria Biotherapeutics and the MD Anderson Cancer Center: Apollo Therapeutics’ cardio-metabolic pact: The company will pay $12 million upfront and up ...